Experimental research has demonstrated that NOP2 promoted cell proliferation in vivo and in vitro through RAPGEF4, and enhanced the migration and invasion ability of high-grade serous ovarian cancer cells in vitro. This evidence concerns the gene NOP2 and ovarian serous adenocarcinoma.